Here are four takeaways:
1. The average 12-month price target for the stock among brokerages is $18.76.
2. The company’s market capitalization is $153,981.
3. The company’s 50 day moving average is $17.66 and its 200-day moving average is $17.45.
4. Smith & Nephew has a one-year low of $13.46 and a one-year high of $18.58.
More articles on devices:
Next generation intellijoint HIP successfully used in first surgeries: 3 things to know
Medtronic dominates European VCF market — 8 trends to watch
Titan Spine signs distribution agreement for Europe: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
